|Systematic (IUPAC) name|
Dextran, 2,3-dihydroxypropyl 2-hydroxy-1,3-propanediyl ethers
|AHFS/Drugs.com||International Drug Names|
|ATC code||D03AX02 (WHO)|
|(what is this?)|
Dextranomer (trade name Debrisan) is a cicatrizant used in dressings for wound healing, and in pharmaceutical products to treat fecal incontinence. It consists of dextran polymer chains cross-linked into a three-dimensional network.
Solesta is the marketed brand name of a system of injections of dextranomer in stabilized sodium hyaluronate for use in fecal incontinence (FI). This preparation is a biocompatible gel, for use as a perianal injectable bulking agent. The system is intended to be injected in the submucosal layer of the proximal anal canal (i.e. above the level of the dentate line).
- Parulkar BG, Sobti MK, Pardanani DS (1985). "Dextranomer dressing in the treatment of infected wounds and cutaneous ulcers". J Postgrad Med. 31 (1): 28–33.
- Solesta Gel Approved for Fecal Incontinence
- Solesta Package Insert
- Hoy, SM (Aug 20, 2012). "Dextranomer in stabilized sodium hyaluronate (Solesta): in adults with faecal incontinence.". Drugs. 72 (12): 1671–8. doi:10.2165/11209030-000000000-00000. PMID 22845415.
|This dermatologic drug article is a stub. You can help Wikipedia by expanding it.|